By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Includes articles, courses, and CPGs. Unlimited access for APTA members.
Jun 13, 2016/Clinical Summary
THA to improve hip joint stability, mobility, locomotion, and quality of life is considered one of the most successful surgical procedures.
Jun 26, 2016/Test & Measure
The BESS test was developed as an outcome measure of postural stability. It is often used in the population of athletes with concussion or mild traumatic brain injury.
Jul 1, 2016/CPG
Evidence-based guideline for the management of grades I–III neck pain and associated disorders (NAD) for adults with grades I–III NAD for less than 6 months.
Evidence-based guideline for the management of grades I–III neck pain and associated disorders (NAD). [Subscription or purchase required.]
Jul 24, 2016/Test & Measure
Assesses self-care, mobility, and social functioning in children aged 6 months to 7 years.
Jan 1, 2022/CPG
This guideline, from the New Zealand government, is for people with autism spectrum disorder (ASD), their families and carers, health and disability professionals, community supporters, employers, policy advisers, and anyone involved in education. Recommendations address diagnosis and initial assessment,
Jun 14, 2021/CPG
Covers the different ways that health and social care professionals can provide support and treatment for children and young people with autism, their families and carers.
May 1, 2020/CPG
Recommendations, updated in 2020, from the American Association of Clinical Endocrinologists and American College of Endocrinology on the diagnosis, evaluation, and treatment of postmenopausal osteoporosis for endocrinologists, physicians, regulatory bodies, health-related organizations, and interested
Sep 1, 2016/CPG
Examines the condition of brain trauma clinical research, how this condition is defining and shaping our future and proposes a solution in establishing a formal evidence-based consortium.
Aug 28, 2019/CPG
Covers identifying and treating primary hypertension in people aged 18 and over, including people with type 2 diabetes.
